NovoCure NVCR
NASDAQ NVCR
$15.95 -0.04 (-0.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

NovoCure (NVCR) Common Equity (2014 - 2026)

Updated

NovoCure (NVCR) reported Common Equity of $338.09 million for Q2 2026, down 3.2% from $349.44 million a year earlier but up 2.2% from the prior quarter.

Analysis

NovoCure (NVCR) Common Equity (2014 - 2026) Analysis & Trends

At the end of FY2025, NovoCure posted Common Equity of $340.47 million, down 5.5% from FY2024.

  • Common Equity has declined for three consecutive years, with a five-year compound annual growth rate of -6.5% (FY2020 to FY2025).
  • By year, Common Equity came in at $360.18 million in FY2024 (-0.6%), $362.5 million in FY2023 (-17.8%), $441.17 million in FY2022 (+7.5%) and $410.49 million in FY2021 (-13.9%).
  • Five-year quarterly Common Equity spans a low of $330.72 million in Q1 2026 and a high of $445.4 million in Q3 2022.
  • Year over year, Common Equity has now declined in each of the last five quarters, with an average decline of 4.3% over the last eight quarters.
  • The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 34.6%); the low point was Q4 2023 (a decline of 17.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $330.72 million (Q1 2026), $340.47 million (Q4 2025) and $341.33 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 52.69 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 51.76 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 52.59 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 18.30 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 50.85 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 23.99 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 25.17 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 10.72 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.42 Bn
10 NovoCure 1.86 Bn -491.82 Mn 142.48 Mn 338.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 338.09 Mn
Mar 31, 2026 330.72 Mn
Dec 31, 2025 340.47 Mn
Sep 30, 2025 341.33 Mn
Jun 30, 2025 349.44 Mn
Mar 31, 2025 361.96 Mn
Dec 31, 2024 360.18 Mn
Sep 30, 2024 360.78 Mn
Jun 30, 2024 361.75 Mn
Mar 31, 2024 359.36 Mn
Dec 31, 2023 362.50 Mn
Sep 30, 2023 393.70 Mn
Jun 30, 2023 415.68 Mn
Mar 31, 2023 432.15 Mn
Dec 31, 2022 441.17 Mn
Sep 30, 2022 445.40 Mn
Jun 30, 2022 441.67 Mn
Mar 31, 2022 435.88 Mn
Dec 31, 2021 410.49 Mn
Sep 30, 2021 413.16 Mn
API Access

NovoCure Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NVCR&period=max&api_key=YOUR_API_KEY